Teva Pharmaceutical Industries (TEVA) Equity Ratio: 2009-2025
Historic Equity Ratio for Teva Pharmaceutical Industries (TEVA) over the last 10 years, with Sep 2025 value amounting to 0.18.
- Teva Pharmaceutical Industries' Equity Ratio rose 19.07% to 0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18, marking a year-over-year increase of 19.07%. This contributed to the annual value of 0.14 for FY2024, which is 26.80% down from last year.
- As of Q3 2025, Teva Pharmaceutical Industries' Equity Ratio stood at 0.18, which was up 6.88% from 0.17 recorded in Q2 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Equity Ratio registered a high of 0.24 during Q3 2021, and its lowest value of 0.14 during Q4 2024.
- Over the past 3 years, Teva Pharmaceutical Industries' median Equity Ratio value was 0.18 (recorded in 2023), while the average stood at 0.17.
- As far as peak fluctuations go, Teva Pharmaceutical Industries' Equity Ratio declined by 26.80% in 2024, and later rose by 19.07% in 2025.
- Over the past 5 years, Teva Pharmaceutical Industries' Equity Ratio (Quarterly) stood at 0.24 in 2021, then declined by 17.18% to 0.20 in 2022, then dropped by 4.33% to 0.19 in 2023, then decreased by 26.80% to 0.14 in 2024, then grew by 19.07% to 0.18 in 2025.
- Its last three reported values are 0.18 in Q3 2025, 0.17 for Q2 2025, and 0.16 during Q1 2025.